We can't find the internet
Attempting to reconnect
25617.1 PFLS-LS
Validation and optimiztion of a screening platform for the study of liver disease (fibrosis and NASH)
Zusammenfassung
Validation and optimiztion of a screening platform for the study of liver disease (fibrosis and NASH)
Weitere Texte
Abstract
Within the CTI Project No. 16856.1 PFLS-LS we successfully implemented a human in vitro model containing functional hepatocytes, Kupffer and stellate cells for the investigation of liver fibrosis. In this follow-up project, we aim at validating the model with additional pro-fibrotic and antifibrotic stimuli. We will also assess the suitablity of the system for the investigation of NASH and its relationship with fibrosis. In addition, we will implement shipping tests for the product.
Beteiligte
David Fluri
Wirtschaftspartner
david.fluri@insphero.com
InSphero AG CHE-114.790.768 David Fluri Wagistrasse 27 8952 Schlieren ZH CH
Laura Suter-Dick
Kontaktperson
Laura.suterdick@fhnw.ch
FHNW Fachhochschule Nordwestschweiz Hochschule für Life Sciences Laura Suter-Dick Gründenstrasse 40 4132 Muttenz BL CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2017-04-30
- Enddatum
- 2018-08-31
- Bewilligte Gesamtkosten
- CHF 162809.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%